Latest Breaking News On - Ngitix announces expanded collaboration and licensing agreement with takeda to develop new anti fibrotic therapies in inflammatory bowel disease - Page 1 : comparemela.com

Engitix Announces Expanded Collaboration and Licensing Agreement with Takeda to Develop New Anti-Fibrotic Therapies in Inflammatory Bowel Disease - read this article along with other careers information, tips and advice on BioSpace

United kingdomCity ofGiuseppe mazzaMike plattExscalate dompGareth hicksDigestive healthUniversity college londonDivision of medicineEngitix ltdInstitute for liverDiscovery unitWhite city placeNetherton investmentsNgitix announces expanded collaboration and licensing agreement with takeda to develop new anti fibrotic therapies in inflammatory bowel disease